Cargando…
Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model
Psoriasis is a chronic inflammatory skin disease characterized by well-defined scaly papules and plaques. Interleukin (IL)-17 is involved in its pathogenesis and promotes the proliferation of epidermal keratinocytes through signal transducer and activator of transcription 3 (STAT3) activation. Shiko...
Autores principales: | Lan, Xiao-Ou, Wang, He-Xiao, Qi, Rui-Qun, Xu, Yuan-Yuan, Yu, Ya-Jie, Yang, Yang, Guo, Hao, Gao, Xing-Hua, Geng, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411367/ https://www.ncbi.nlm.nih.gov/pubmed/32705251 http://dx.doi.org/10.3892/mmr.2020.11315 |
Ejemplares similares
-
Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways
por: JING, HUILING, et al.
Publicado: (2016) -
Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice
por: Choi, Mi Ran, et al.
Publicado: (2021) -
Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice
por: Gao, Jintao, et al.
Publicado: (2020) -
Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A
por: Yuan, Li-li, et al.
Publicado: (2023) -
Alantolactone Suppresses Proliferation and the Inflammatory Response in Human HaCaT Keratinocytes and Ameliorates Imiquimod-Induced Skin Lesions in a Psoriasis-Like Mouse Model
por: Chuo, Wen-Ho, et al.
Publicado: (2021)